Diversified Enterprises’s AbbVie ABBV Stock Holding History

Diversified Enterprises’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.2M	Sell	12,729 -473	-4%	-$102K	0.16%	70
2026 Q1	$2.87M	Buy	13,202 +219	+2%	+$48.6K	0.16%	64
2025 Q4	$2.97M	Buy	12,983 +3,478	+37%	+$792K	0.18%	58
2025 Q3	$2.2M	Buy	9,505 +587	+7%	+$120K	0.15%	61
2025 Q2	$1.66M	Sell	8,918 -151	-2%	-$28.1K	0.12%	67
2025 Q1	$1.9M	Buy	9,069 +1,455	+19%	+$283K	0.16%	60
2024 Q4	$1.35M	Buy	7,614 +642	+9%	+$118K	0.13%	58
2024 Q3	$1.38M	Buy	+6,972	New	+$1.3M	0.15%	61

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Diversified Enterprises's ABBV Position: Q2 2026 in Review

Diversified Enterprises reduced its AbbVie (ABBV) stake by 3.6% in Q2 2026, selling an estimated $102K and leaving 12,729 shares worth $3.2M. The position accounts for 0.16% of the portfolio, ranked #70.

Diversified Enterprises first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Diversified Enterprises held 12,729 shares of AbbVie worth $3.2M as of Q2 2026.
Diversified Enterprises sold 473 AbbVie shares in Q2 2026, an estimated $102K.
AbbVie made up 0.16% of Diversified Enterprises's portfolio in Q2 2026, its #70 holding.
Diversified Enterprises first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Diversified Enterprises's 13F filing for Q2 2026, filed 31 Jul 2026.